The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells

Tabetha Sundin1, Dennis M Peffley, David Gauthier

  • 1Department of Biological Sciences, Old Dominion University, Norfolk, VA 23529, USA.

Biochimie
|August 21, 2012
PubMed

Insights

Perillyl alcohol and rapamycin rapidly suppress telomerase activity in prostate cancer cells by reducing hTERT protein levels via proteasomal degradation, not affecting hTERT mRNA.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Isoprenoids, like perillyl alcohol, can suppress cancer development.
  • Mechanistic target of rapamycin (mTOR) signaling is modulated by perillyl alcohol.
  • Telomerase is reactivated in early-stage cancer cells, contributing to cellular immortality.

Purpose of the Study:

  • To investigate the effects of perillyl alcohol and an mTOR inhibitor, rapamycin, on telomerase activity in prostate cancer cells.
  • To elucidate the molecular mechanisms underlying changes in telomerase activity.

Main Methods:

  • Treatment of prostate cancer cell lines with perillyl alcohol or rapamycin.
  • Assay of telomerase activity using quantitative telomerase repeat amplification protocol and polyacrylamide gel electrophoresis.
  • Analysis of human telomerase reverse transcriptase (hTERT) mRNA and protein levels via real-time RT-PCR and Western blot.
  • Investigation of proteasomal degradation involvement using MG-132.

Main Results:

  • Rapid and significant suppression of telomerase activity (65% to >95%) was observed with both perillyl alcohol and rapamycin.
  • hTERT mRNA levels remained unchanged, but hTERT protein levels decreased.
  • Proteasome inhibitor MG-132 partially blocked the decrease in hTERT protein, indicating proteasomal degradation.
  • No alteration in hTERT phosphorylation at Ser824 was detected.

Conclusions:

  • Perillyl alcohol and rapamycin effectively reduce telomerase activity in prostate cancer cells.
  • The mechanism involves increased proteasomal degradation of hTERT protein, independent of hTERT mRNA levels or phosphorylation.
  • This study reveals a novel link between mTOR signaling and hTERT regulation, impacting DNA stability in cancer.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...